The "Affordable Medicines" program in Ukraine has been expanded to include 51 additional drugs
The Cabinet of Ministers of Ukraine has expanded the "Affordable Medicines" program by adding 51 more international nonproprietary names (INNs) to the list. The updated list will take effect in July 2026 and will cover treatment for the most common cardiovascular diseases.
Ukraine has decided to expand one of the most important medical programs for patients, and has now added 51 new international non-proprietary names (INNs) to the “Affordable Medicines” list—drugs that help people manage blood pressure, heart disease, and stroke risks.
Ukrainian Prime Minister Yulia Svyrydenko announced that the updated list will take effect in July 2026, and will include medications for treating heart failure, arrhythmias, preventing blood clots, lowering cholesterol, as well as medications for patients who have had a heart attack or those at high risk of stroke. “The updated list, which will take effect in July 2026, will include an additional 51 international nonproprietary names of medicines,” Svyrydenko noted, emphasizing that the program covers an increasing number of treatment areas.
The “Affordable Medicines” program itself allows Ukrainians to receive necessary medications free of charge or with a partial copayment via an electronic prescription, and, according to government data, its budget grew to 8.7 billion hryvnias in 2026, and more than 6 million people have already benefited from it since its launch.
To obtain such medications, a patient must consult a doctor, obtain an electronic prescription, and visit a pharmacy participating in the program, marked with the sign “Affordable Medicines Available Here,” which significantly simplifies access to necessary treatment.
Separately, the government emphasizes that Ukrainian manufacturers can gain an advantage when drugs are included in the program if their products meet the requirements and have the lowest price, which simultaneously supports the domestic pharmaceutical industry and ensures a stable supply of medicines to patients. This was announced by Ukrainian Prime Minister Yulia Svyrydenko.
